Wegovy Study Bolsters Use In Patients With Obesity and Heart Disease

Weight-Loss Drugs Among the Most Sought-After New Corporate Benefits

Soho House Revenue Falls Short Despite 21% Membership Growth

Novo to Build $6 Billion Plant as Obesity Drug Demand Surges

Asia Markets Under Pressure After Treasuries Slip : Markets Wrap

Buffett’s Cash at Record $157 Billion After Deal Slump

The First Commercial Carbon-Sucking Facility in the US Opens in California

Astra Enters Obesity Drug Race With Chinese Biotech Deal

Japanese Funds Buy Most US Debt in Half Year, Pressuring Yen

China Healthcare Stocks On Recovery Path After $142 Billion Rout

New Ozempic Rival Is About to Make Your Weight Loss Drugs Cheaper

Asian Stocks to Climb as S&P 500 Hits Hot Streak: Markets Wrap